John E. Kao - Mar 8, 2022 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Role: Chief Executive Officer, Director
Signature: /s/ Richard A. Cross, as Attorney-in-Fact, for John E. Kao
Stock symbol: ALHC
Transactions as of: Mar 8, 2022
Transactions value $: $0
Form type: 4
Date filed: 3/10/2022, 04:21 PM
Previous filing: Nov 24, 2021
Next filing: Apr 1, 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALHC	Common Stock	Award	$0	+497K	+159.69%	$0.00	808K	Mar 8, 2022	Direct	F1
holding	ALHC	Common Stock						3.57M	Mar 8, 2022	See Footnote	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALHC	Options (Right to Buy)	Award	$0	+365K		$0.00	365K	Mar 8, 2022	Common Stock	365K	$9.06	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents 496,689 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.
F2	Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.
F3	Options vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.